Las Vegas, NV -- (SBWIRE) -- 11/04/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Discovery Laboratories, Inc. (NASDAQ:DSCO), Quantum Fuel Systems Tech Worldwide Inc (NASDAQ:QTWW), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Celsion Corporation (NASDAQ:CLSN)
Discovery Laboratories, Inc. (NASDAQ:DSCO) managed to keep its fall at -2.43% on below -normal volume of 1.28M shares. The stock settled at $2.01 after floating in a range of $2 to $2.06. Its latest price has reached market capitalization of $11.12 million. Its 52-week range has been $1.50 to $3.05. Discovery Laboratories, Inc. is a biotechnology company focused on creating life-saving products for critical care patients with respiratory disease.
Has DSCO Found The Bottom and Ready To Move Up? Find Out Here
Quantum Fuel Systems Tech Worldwide Inc (NASDAQ:QTWW) traded up on a volume of 1.26 million, higher than its standard daily volume. Shares have gained 2.52% to $4.89. Over the last twelve months, the stock has gained 72.18% and faced a worst price of $1.85. Quantum Fuel Systems Technologies Worldwide, Inc. engages in the design, development, and production of compressed natural gas (CNG) storage tanks and packaged fuel systems, and other fuel and propulsion systems for alternative fuel vehicle applications in the United States and internationally.
For How Long QTWW’s Gloss will Attract Investors? Find out via this report
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) settled 1% higher at $2.53 on below -normal volume of 1.29M shares during the last trading day. The stock has its 12-month high at $10.17 and 52-week low price was $2.26. It traded in a range of $2.41 to $2.54 during the last trading day. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
Why Should Investors Buy ACHN After the Recent Fall? Just Go Here and Find Out
In the last trading session, Celsion Corporation (NASDAQ:CLSN) was up on high volume, trading at a volume of 1.25M shares versus its average daily volume of 409,102.00 shares. At $4.29, the stock has attained market capitalization of $58.31 million. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.
Will CLSN Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)